References of "Hughes, C"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailInfluence of baseline patient characteristics on response to one-monthly and daily oral ibandronate therapy: 2-year findings from MOBILE
Reginster, Jean-Yves ULg; Hawker, G.; Bolognese, M. et al

in Annals of the Rheumatic Diseases (2006, June), 65(Suppl.II), 426

Detailed reference viewed: 7 (3 ULg)
Full Text
Peer Reviewed
See detailOnce-monthly dosing of oral ibandronate is highly efficacious: 2-year results from mobile
Reginster, Jean-Yves ULg; Stakkestad, J. A.; Lorenc, R. et al

in Osteoporosis International (2006, March), 17(Suppl.1), 64-65

Detailed reference viewed: 1 (0 ULg)
Full Text
Peer Reviewed
See detailIntravenous ibandronate injections are at least as effective as daily oral ibandronate: consistent effect across subgroups
Reginster, Jean-Yves ULg; Stepan, J. J.; Halse, J. et al

in Annals of the Rheumatic Diseases (2005, June), 64(Suppl.III), 365

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailOnce-monthly and daily oral ibandronate are at least as effective in improving proximal femur BMD in postmenopausal osteoporosis: 12-month data from MOBILE
Reginster, Jean-Yves ULg; Lorenc, R.; Stepan, J. J. et al

in Annals of the Rheumatic Diseases (2005, June), 64(Suppl.III), 93

Detailed reference viewed: 2 (1 ULg)
Full Text
Peer Reviewed
See detailTwo-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: the MOBILE study
Cooper, C.; Delmas, P. D.; Felsenberg, D. et al

in Annals of the Rheumatic Diseases (2005, June), 64(Suppl.III), 68

Detailed reference viewed: 11 (5 ULg)
Full Text
Peer Reviewed
See detailMonthly oral ibandronate is at least as effective as daily oral ibandronate: 1-year results from MOBILE
Reginster, Jean-Yves ULg; Cooper, Cyrus; Miller, P. D. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 81-82

Detailed reference viewed: 4 (0 ULg)
Full Text
Peer Reviewed
See detailIntermittent intravenous ibandronate injections and daily oral ibandronate provide at least equivalent increases in bone mineral density: 1-year results from DIVA
Delmas, P. D.; Sambrook, P.; Recker, R. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 7

Detailed reference viewed: 3 (0 ULg)
Full Text
Peer Reviewed
See detailOnce-monthly dosing of oral ibandronate is at least as effective as daily dosing in postmenopausal osteoporosis : 1-year results from mobile
Reginster, Jean-Yves ULg; Zikan, V.; Lorenc, R. et al

in BONE (2005), 36(S2), 416

Detailed reference viewed: 3 (1 ULg)
Full Text
Peer Reviewed
See detailMonthly oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis : 1-year results from mobile
Cooper, C.; Stepan, J. J.; Lorenc, R. et al

in BONE (2005), 36(S2), 417

Detailed reference viewed: 2 (1 ULg)
Full Text
Peer Reviewed
See detailGalectins: a family of animal beta-galactoside-binding lectins.
Barondes, S. H.; Castronovo, Vincenzo ULg; Cooper, D. N. et al

in Cell (1994), 76(4), 597-8

Detailed reference viewed: 191 (3 ULg)